How does methotrexate work and why is folic acid (Vitamin B9) supplementation necessary?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methotrexate Mechanism and Folic Acid Supplementation

Methotrexate works as a folate antagonist that inhibits dihydrofolate reductase, interfering with purine and pyrimidine synthesis, and folic acid supplementation is necessary to reduce toxicity without compromising treatment efficacy. 1

Mechanism of Action of Methotrexate

  • Methotrexate functions as a folic acid antagonist, which interferes with purine and pyrimidine synthesis, thus impairing nucleotide production 2
  • At low doses used for inflammatory conditions, methotrexate primarily decreases proliferation of lymphoid cells through direct immunosuppressive effects rather than affecting epidermal cells 2
  • Methotrexate competitively inhibits dihydrofolate reductase, decreasing folate cofactors required for nucleic acid synthesis 3
  • Polyglutamate derivatives of methotrexate act as inhibitors of dihydrofolate reductase and thymidylate synthetase, which can remain in tissues for extended periods 3
  • Methotrexate also increases endogenous adenosine, an anti-inflammatory molecule, through inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase 2

Necessity of Folic Acid Supplementation

  • The American Academy of Dermatology strongly recommends folate supplementation for all patients taking methotrexate to reduce the incidence of adverse effects 2, 1
  • Folic acid supplementation helps replenish folate stores depleted by methotrexate, reducing side effects while maintaining therapeutic efficacy 1
  • Without folate supplementation, patients are at higher risk for developing:
    • Gastrointestinal toxicity (nausea, vomiting, stomatitis) 4
    • Bone marrow suppression (leucopenia) 5
    • Hepatotoxicity (elevated liver enzymes) 6
    • Fatigue and malaise 4

Dosing Recommendations for Folic Acid

  • Standard recommendation is 1-5 mg of folic acid daily, except on the day(s) of methotrexate administration 1, 4
  • Folic acid should be taken 6 days per week (avoiding the day of methotrexate) to prevent interference with methotrexate efficacy 1
  • At minimum, at least 5 mg of folic acid per week is strongly recommended 1
  • Folic acid is preferred over folinic acid (leucovorin) for routine supplementation due to lower cost and similar effectiveness 1, 6

Evidence for Folic Acid Benefits

  • Systematic reviews have demonstrated that folic acid supplementation reduces hepatic side effects by approximately 35.8% in patients on methotrexate 6
  • Daily use of folic acid does not appear to affect methotrexate efficacy, whereas folinic acid given close to methotrexate administration may reduce effectiveness 7
  • Studies show folate supplementation reduces the discontinuation rate of methotrexate therapy due to side effects 8
  • Folate supplementation has been shown to decrease methotrexate-induced hyperhomocysteinemia, which may have cardiovascular benefits 8

Common Pitfalls and Caveats

  • Avoid administering folic acid on the same day as methotrexate to prevent potential interference with efficacy 1
  • Do not confuse folic acid (for routine supplementation) with folinic acid/leucovorin (used primarily for methotrexate toxicity rescue) 7
  • Regular monitoring of complete blood counts, liver function, and renal function remains essential even with folate supplementation 4
  • Patients with renal insufficiency require dose adjustments of methotrexate, as impaired clearance increases toxicity risk 2, 3
  • Nausea is one of the most common side effects of methotrexate (up to 25% of patients), and folic acid supplementation can help reduce this symptom 2

By understanding the mechanism of methotrexate and implementing appropriate folic acid supplementation, clinicians can significantly reduce toxicity while maintaining therapeutic efficacy in inflammatory conditions.

References

Guideline

Methotrexate and Folic Acid Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Methotrexate Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Methotrexate-Induced Leucopenia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Reducing toxicity of methotrexate with folic acid].

Zeitschrift fur Rheumatologie, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.